Xenetic Biosciences Inc. [NASDAQ: XBIO] jumped around 0.14 points on Wednesday, while shares priced at $1.05 at the close of the session, up 15.96%.
Xenetic Biosciences Inc. stock is now -27.08% down from its year-to-date (YTD) trading value. XBIO Stock saw the intraday high of $1.14 and lowest of $0.90 per share. The company’s 52-week high price is 1.96, which means current price is +138.64% above from all time high which was touched on 01/22/20.
Compared to the average trading volume of 533.54K shares, XBIO reached a trading volume of 1682163 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Xenetic Biosciences Inc. [XBIO]?
Maxim Group have made an estimate for Xenetic Biosciences Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 08, 2020.
The Average True Range (ATR) for Xenetic Biosciences Inc. is set at 0.09, with the Price to Sales ratio for XBIO stock in the period of the last 12 months amounting to 33.18. The Price to Book ratio for the last quarter was 0.43, with the Price to Cash per share for the same quarter was set at 1.28.
How has XBIO stock performed recently?
Xenetic Biosciences Inc. [XBIO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 26.51. With this latest performance, XBIO shares dropped by -19.85% in over the last four-week period, additionally plugging by 104.20% over the last 6 months – not to mention a drop of -32.26% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for XBIO stock in for the last two-week period is set at 48.79, with the RSI for the last a single of trading hit 61.70, and the three-weeks RSI is set at 50.46 for Xenetic Biosciences Inc. [XBIO]. The present Moving Average for the last 50 days of trading for this stock 1.1148, while it was recorded at 0.9161 for the last single week of trading, and 1.1018 for the last 200 days.
Xenetic Biosciences Inc. [XBIO]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Xenetic Biosciences Inc. [XBIO] shares currently have an operating margin of -56272.41. Xenetic Biosciences Inc.’s Net Margin is presently recorded at -74856.59.
Return on Total Capital for XBIO is now -70.75, given the latest momentum, and Return on Invested Capital for the company is -94.19. Return on Equity for this stock declined to -94.19, with Return on Assets sitting at -71.02. When it comes to the capital structure of this company, Xenetic Biosciences Inc. [XBIO] has a Total Debt to Total Equity ratio set at 0.12. Additionally, XBIO Total Debt to Total Capital is recorded at 0.12, with Total Debt to Total Assets ending up at 0.09.
Reflecting on the efficiency of the workforce at the company, Xenetic Biosciences Inc. [XBIO] managed to generate an average of -$3,193,756 per employee.Xenetic Biosciences Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 11.60 and a Current Ratio set at 11.60.
Insider trade positions for Xenetic Biosciences Inc. [XBIO]
There are presently around $0 million, or 2.80% of XBIO stock, in the hands of institutional investors. The top three institutional holders of XBIO stocks are: RENAISSANCE TECHNOLOGIES LLC with ownership of 173,197, which is approximately 5.533% of the company’s market cap and around 14.72% of the total institutional ownership; OXFORD ASSET MANAGEMENT LLP, holding 54,750 shares of the stock with an approximate value of $57000.0 in XBIO stocks shares; and ROYAL BANK OF CANADA, currently with $28000.0 in XBIO stock with ownership of nearly 0% of the company’s market capitalization.
Positions in Xenetic Biosciences Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 2 institutional holders increased their position in Xenetic Biosciences Inc. [NASDAQ:XBIO] by around 63,830 shares. Additionally, 2 investors decreased positions by around 60,534 shares, while 4 investors held positions by with 130,976 shares. The mentioned changes placed institutional holdings at 255,340 shares, according to the latest SEC report filing. XBIO stock had 1 new institutional investments in for a total of 54,750 shares, while 2 institutional investors sold positions of 60,534 shares during the same period.